OCTAGON CAPITAL ADVISORS LP 13F Portfolio
OCTAGON CAPITAL ADVISORS LP runs OCTAGON CAPITAL ADVISORS LP and currently holds 27 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $1.11B. Their top holdings are DNTH, DFTX, ABVX, COGT, ALMS. The top five represent 55.8% of reported portfolio weight. OCTAGON CAPITAL ADVISORS LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, OCTAGON CAPITAL ADVISORS LP initiated 2 new positions. They added to 3 existing positions. They trimmed 4 positions. Their current best-performing preview position is DFTX with returns of +148.89%.
Portfolio Value
$1.11B
Alpha Score
127.1
#0 of 1000
Holdings
27
OCTAGON CAPITAL ADVISORS LP Current 13F Holdings
Reported holdings from OCTAGON CAPITAL ADVISORS LP's latest SEC 13F filing, ranked by portfolio weight.
27 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 DNTH DIANTHUS THERAPEUTICS INC | 16.14% | $23.81 | $82.37 | +245.95% | Trimmed -5.39% |
 DFTX DEFINIUM THERAPEUTICS INC | 12.47% | $23.76 | $36.90 | +55.30% | Added +20.90% |
 ABVX ABIVAX SA | 11.89% | $49.04 | $88.15 | +79.75% | Added +46.68% |
 COGT COGENT BIOSCIENCES INC | 8.17% | $9.42 | $31.00 | +229.09% | Held |
 ALMS ALUMIS INC | 7.16% | $11.06 | $7.16 | -35.26% | Held |
 AVBP ARRIVENT BIOPHARMA INC | 6.15% | $19.07 | $16.73 | -12.27% | Held |
 BIOA BIOAGE LABS INC | 3.85% | $13.60 | $6.34 | -53.38% | Held |
 MIRM MIRUM PHARMACEUTICALS INC | 3.57% | $92.38 | $86.01 | -6.90% | Held |
 KYMR KYMERA THERAPEUTICS INC | 3.20% | $57.09 | $112.40 | +96.88% | Trimmed -27.06% |
 AKTS AKTIS ONCOLOGY INC | 2.78% | $17.89 | $18.15 | +1.45% | Held |
Showing 1-10 of 27